rs2395272
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001368882.1(COL13A1):c.463-4G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.168 in 1,603,484 control chromosomes in the GnomAD database, including 27,850 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001368882.1 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL13A1 | NM_001368882.1 | c.463-4G>A | splice_region_variant, intron_variant | ENST00000645393.2 | NP_001355811.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL13A1 | ENST00000645393.2 | c.463-4G>A | splice_region_variant, intron_variant | NM_001368882.1 | ENSP00000496051.1 |
Frequencies
GnomAD3 genomes AF: 0.195 AC: 29624AN: 151806Hom.: 3291 Cov.: 32
GnomAD3 exomes AF: 0.219 AC: 53842AN: 245334Hom.: 7248 AF XY: 0.217 AC XY: 28948AN XY: 133630
GnomAD4 exome AF: 0.165 AC: 239223AN: 1451562Hom.: 24543 Cov.: 31 AF XY: 0.168 AC XY: 121714AN XY: 722590
GnomAD4 genome AF: 0.195 AC: 29661AN: 151922Hom.: 3307 Cov.: 32 AF XY: 0.201 AC XY: 14933AN XY: 74258
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Congenital myasthenic syndrome 19 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 22, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at